Ginkgo Bioworks (DNA) Misses Q1 EPS by 2c

Ginkgo Bioworks (NYSE: DNA) reported Q1 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $80.7 million versus the consensus estimate of $70.75 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• Phoenix Education Partners, Inc. (PXED) Misses Q3 EPS by 14c; Offers Outlook
• This eVTOL stock just got downgraded at Goldman
• Pentair cuts 2026 outlook, names interim CFO after pool slump